Literature DB >> 10680150

Neurocognitive dysfunction in cancer patients.

C A Meyers1.   

Abstract

Many cancer patients experience impairments of neurocognitive function, including memory loss, distractibility, difficulty in performing multiple tasks (multitasking), and a myriad of other symptoms. Patients may also concurrently suffer from mood disturbance and symptoms that compromise their ability to function adequately, including fatigue and pain. The etiologies of these problems are diverse and include the direct effects of cancer within the central nervous system (CNS), indirect effects of certain cancers (e.g., paraneoplastic brain disorders), and both diffuse and highly specific effects of cancer treatments on the brain. In addition to these cancer-related causes, patients may have coexisting neurologic or psychiatric disorders that affect their cognition and mood. Careful assessment of patients complaining of neurocognitive or behavioral problems is essential to providing appropriate interventions and maximizing their ability to carry out usual activities.

Entities:  

Mesh:

Year:  2000        PMID: 10680150

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  50 in total

1.  Defining the optimal window for cranial transplantation of human induced pluripotent stem cell-derived cells to ameliorate radiation-induced cognitive impairment.

Authors:  Munjal M Acharya; Vahan Martirosian; Lori-Ann Christie; Lara Riparip; Jan Strnadel; Vipan K Parihar; Charles L Limoli
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

2.  Cranial irradiation compromises neuronal architecture in the hippocampus.

Authors:  Vipan Kumar Parihar; Charles L Limoli
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

Review 3.  A lifespan approach to neuroinflammatory and cognitive disorders: a critical role for glia.

Authors:  Staci D Bilbo; Susan H Smith; Jaclyn M Schwarz
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-06       Impact factor: 4.147

4.  Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.

Authors:  Pierre Montay-Gruel; Munjal M Acharya; Kristoffer Petersson; Leila Alikhani; Chakradhar Yakkala; Barrett D Allen; Jonathan Ollivier; Benoit Petit; Patrik Gonçalves Jorge; Amber R Syage; Thuan A Nguyen; Al Anoud D Baddour; Celine Lu; Paramvir Singh; Raphael Moeckli; François Bochud; Jean-François Germond; Pascal Froidevaux; Claude Bailat; Jean Bourhis; Marie-Catherine Vozenin; Charles L Limoli
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-16       Impact factor: 11.205

5.  Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.

Authors:  Patricia A Ganz; Lorna Kwan; Steven A Castellon; Amy Oppenheim; Julienne E Bower; Daniel H S Silverman; Steve W Cole; Michael R Irwin; Sonia Ancoli-Israel; Thomas R Belin
Journal:  J Natl Cancer Inst       Date:  2013-04-19       Impact factor: 13.506

6.  Functional consequences of radiation-induced oxidative stress in cultured neural stem cells and the brain exposed to charged particle irradiation.

Authors:  Bertrand P Tseng; Erich Giedzinski; Atefeh Izadi; Tatiana Suarez; Mary L Lan; Katherine K Tran; Munjal M Acharya; Gregory A Nelson; Jacob Raber; Vipan K Parihar; Charles L Limoli
Journal:  Antioxid Redox Signal       Date:  2013-08-12       Impact factor: 8.401

7.  Defining functional changes in the brain caused by targeted stereotaxic radiosurgery.

Authors:  Vipan K Parihar; Munjal M Acharya; Dante E Roa; Omar Bosch; Lori-Ann Christie; Charles L Limoli
Journal:  Transl Cancer Res       Date:  2014-04-01       Impact factor: 1.241

Review 8.  Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.

Authors:  Christine D Craig; Bradley J Monk; John H Farley; Dana M Chase
Journal:  Support Care Cancer       Date:  2013-11-10       Impact factor: 3.603

9.  Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?

Authors:  Patricia A Ganz; J E Bower; L Kwan; S A Castellon; D H S Silverman; C Geist; E C Breen; M R Irwin; S W Cole
Journal:  Brain Behav Immun       Date:  2012-08-03       Impact factor: 7.217

10.  Early-life programming of later-life brain and behavior: a critical role for the immune system.

Authors:  Staci D Bilbo; Jaclyn M Schwarz
Journal:  Front Behav Neurosci       Date:  2009-08-24       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.